What ADHD Online does

ADHD Online operates a direct-to-consumer telehealth platform for adult ADHD assessment and ongoing treatment, delivered under parent company Mentavi, Inc. (Michigan, USA), founded in 2018. The company's flagship offering is the Mentavi Mental Health Diagnostic Evaluation, a 60–90 minute online assessment priced at $199 that screens for ADHD and co-occurring conditions (anxiety, depression, binge eating disorder, social media addiction, and loneliness) using DSM-5 criteria and validated instruments (GAD-7, PHQ-9, ASRS-2, BEDS-7, Bergen Social Media Addiction Scale, UCLA Loneliness Scale). Results are reviewed by licensed clinical psychologists and delivered within 3–5 days, compared to 2–6 months for traditional in-person evaluation. The platform demonstrates a 95.9% positive predictive value for ADHD diagnosis per a validation study published in the Journal of Clinical Psychiatry (October 2025).

The underlying technology combines a proprietary assessment instrument with AI-assisted administrative workflows (chatbot, appointment management, data organization) layered onto a patient portal hosted at patients.adhdonline.com. Clinical services are delivered through Zoom for teletherapy and through independently operated medical groups (ADO Medical, P.C. and state-specific PC/PA entities) that enable prescribing across jurisdictions. The revenue model is per-service and self-pay: $199 evaluations, $199 initial treatment appointments with $185 follow-ups (averaging ~$899/year for 5 visits), and $220 per 45-minute teletherapy session. The company does not directly bill insurance but provides itemized superbills for reimbursement and accepts HSA/FSA. Distribution channels include a D2C patient portal, healthcare provider referral programs, and a higher education referral pathway targeting college students. Services span all 50 states for diagnostics and 40+ states for treatment and therapy. To date, the company has raised approximately $4M+ in disclosed funding, including a $2M Series AA in July 2023, with Boomerang Ventures, Michigan Capital Network, Wakestream Ventures, Michigan Rise, and Red Cedar Ventures identified as investors.

Name

ADHD Online

Legal name

Mentavi, Inc.

Website

https://adhdonline.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

ADHD Online operates a direct-to-consumer telehealth platform providing a clinically validated $199 adult ADHD Diagnostic Evaluation, medical treatment, and teletherapy services across 40+ U.S. states, under parent company Mentavi, Inc.

Ownership category

akta.pro rank

Product category

Telehealth Mental Health Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Physicians, Mental Health Specialists (621112), Offices of Mental Health Practitioners (except Physicians) (621330)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching) (HLALAEAJ)

akta.pro secondary industry

Psychiatry & Medication Management Platforms (HLALAEAB)

Keywords

• Online ADHD diagnosis
• Telehealth mental health
• ADHD treatment services
• Online therapy sessions
• Mental health assessment

Headquarters

HQ city

Grand Rapids

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Diagnostic Evaluation: One-time $199 fee for comprehensive ADHD assessment reviewed by licensed psychologist. Includes diagnosis (or exclusion) for ADHD, anxiety, and depression within 5 days. Optional 3-installment payment plan ($73/month with $20 admin fee).
2. Medical Treatment: Per-appointment fees for ongoing ADHD treatment: $199 initial appointment, $185 follow-up visits (30-day check-in), with follow-ups every 90 days. May include prescriptions for stimulants or non-stimulants as clinically appropriate.
3. Teletherapy: Virtual therapy sessions with doctorate-level psychologists at $220 per 45-minute session. Offered in 40+ states. Services may be reimbursed by insurance providers.
4. Payment Plan (Klarna): Third-party financing partner Klarna offers 4-interest-free payments for diagnostic evaluation. Mentavi receives full payment upfront from Klarna.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

ADHD Online operates a direct-to-consumer telehealth platform that delivers the Mentavi Mental Health Diagnostic Evaluation—an online, clinician-reviewed ADHD assessment for adults—followed by virtual medical treatment (medication management), teletherapy with doctorate-level psychologists, and prescription services. Services are priced on a per-visit self-pay basis across 40+ US states for treatment and all 50 states for the diagnostic evaluation.

Product overview

ADHD Online, operated by Mentavi Health, offers a unified telehealth platform for adult ADHD assessment and treatment. The core product is the Mentavi Mental Health Diagnostic Evaluation, a clinically validated online assessment that screens for ADHD and co-occurring mental health conditions. Follow-on services include Medical Treatment (virtual appointments with board-certified clinicians for medication management) and Teletherapy (psychotherapy with doctorate-level psychologists). The platform also provides prescription management, patient/provider referral programs, and educational resources including podcasts, webinars, and articles. The Diagnostic Evaluation serves as the prerequisite gateway for all treatment services, with results valid for 18 months. Services are available in 40+ states for adults 18 and over, with the diagnostic evaluation available in all 50 states.

Differentiator

Problem solved

Functional benefit

Products and services

• Mentavi Mental Health Diagnostic Evaluation Clinician-reviewed, 60-90 minute online ADHD assessment for adults, evaluated by licensed clinical psychologists in the patient's home state. Screens for ADHD plus co-occurring anxiety (GAD-7), depression (PHQ-9), binge eating disorder (BEDS-7), problematic social media use (Bergen Social Media Addiction Scale), and loneliness (UCLA Loneliness Scale). Demonstrates 95.9% positive predictive value for ADHD, with results delivered within 5 days. Priced at $199 one-time (available in all 50 US states).
• Medical Treatment Virtual ADHD medical treatment delivered through 1:1 appointments with board-certified, licensed clinicians. Includes personalized treatment planning and medication management (stimulants and non-stimulants as clinically appropriate), with an initial $199 appointment, a $185 30-day progress check-in, and $185 follow-up appointments every 90 days. Available in 40+ US states for adults 18+.
• Teletherapy Online psychotherapy delivered by doctorate-level psychologists with advanced training in clinical or counseling psychology. Offers evidence-based modalities including CBT, DBT, EFT, humanistic therapy, mentalization therapy, psychodynamic therapy, and somatic therapy. Each session is 45 minutes conducted via secure Zoom at $220 per session; may be reimbursed up to 100% by insurance. Available in 40+ US states.
• Prescription Management Prescription services integrated with the Medical Treatment pathway, enabling licensed clinicians to issue and renew prescriptions for ADHD medications including stimulants (Adderall, Ritalin, Vyvanse, Concerta, Focalin XR) and non-stimulants (Strattera, Intuniv, Kapvay, Wellbutrin, Effexor XR). Prescriptions are sent electronically to the patient's local pharmacy.
• Higher Education Referral Program Dedicated referral pathway for college students with suspected ADHD, addressing the estimated 8-10% of incoming college students who have ADHD and the majority who remain undiagnosed due to months-long wait times and lack of resources. Connects higher education institutions and disability services offices with ADHD Online's evaluation pathway to support formal diagnosis and academic accommodations.
• Patient Referral Program Referral program for primary care physicians and mental health professionals to refer patients for ADHD evaluation or comprehensive treatment management. Allows referring providers to choose integration level from assessment-only to full treatment collaboration. ADT Psychiatry is a named integration partner that has embedded the Mentavi Diagnostic Evaluation to standardize adult ADHD assessment across its psychiatric practice.

Quantifiable outcome

• 95.9% positive predictive value for ADHD diagnosis
• +4 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability2 records

Feature3 records

Partnerships

One partnership is on record.

• ADT PsychiatrycoreStrategic or Co-development PartnerADT Psychiatry has integrated Mentavi Health's clinician-reviewed Diagnostic Evaluation to standardize adult ADHD assessment across their psychiatric practice. This partnership validates the platform's clinical utility and demonstrates institutional adoption by established healthcare providers.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Cerebral: Cerebral is a direct-to-consumer telehealth platform providing online ADHD evaluation, medication management, and therapy — overlapping directly with ADHD Online's core offerings. Both target adults seeking accessible ADHD care via online channels with subscription-based medication management.
• Done: Done is a DTC telehealth company specializing in ADHD diagnosis and stimulant prescribing for adults. Like ADHD Online, Done focuses on streamlined online evaluation and ongoing treatment, and has been a subject of DEA scrutiny in the same regulatory context.
• Talkiatry: Talkiatry is a national telepsychiatry practice providing online psychiatric evaluation, medication management, and therapy across a range of conditions including ADHD. It accepts insurance, contrasting with ADHD Online's self-pay model, but competes directly for the same patient segment.
• Klarity: Klarity is an online ADHD clinic offering diagnosis, treatment, and ongoing medication management via telehealth. It serves as a direct competitor to ADHD Online, with a similar provider-led model and emphasis on expedited assessment timelines.
• Brightside Health: Brightside Health is a telehealth platform focused on anxiety and depression treatment with medication and therapy. It is comparable to ADHD Online as a DTC mental health telemedicine operator with a structured clinical pathway and ongoing prescriber relationships.

Broad incumbents

• Hims & Hers: Hims & Hers is a large DTC telehealth platform offering prescriptions and mental health services including ADHD treatment. It is comparable as a broader telehealth incumbent that has expanded into the same ADHD assessment and prescribing category.
• Lyra Health: Lyra Health is an enterprise mental health benefits platform providing therapy, coaching, and psychiatry (including ADHD care) through employer-sponsored plans. Comparable to ADHD Online as a tech-enabled mental health provider, but focused on B2B2C employer distribution rather than pure DTC.
• Spring Health: Spring Health is an employer-sponsored mental health benefits provider offering therapy, coaching, and medication management including ADHD. Like Lyra, it is comparable as a digital mental health platform, though its primary distribution model differs from ADHD Online's direct-to-consumer approach.
• Teladoc Health: Teladoc Health is a large incumbent telehealth provider offering virtual visits across many specialties including mental health and psychiatry. It is comparable as a broad virtual care platform with national reach, though ADHD is a small portion of its portfolio relative to ADHD Online's specialization.
• Amwell: Amwell is an enterprise telehealth platform offering urgent, behavioral, and specialty care including psychiatry. Comparable as a broad telehealth incumbent with established payer and provider relationships that could compete with ADHD Online in the employer and payer channel.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCkWi6OoUOEGV8JI-ZlgZD4g
• Facebookfacebook.com/adhdonline
• LinkedInlinkedin.com/company/adhddiagnosis
• Instagraminstagram.com/adhdonline
• Xx.com/ADHD_ONLINE

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries5 records

Funding overview

Funding rounds3 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ADHD Online